Ranolazine Tablet, Film Coated, Extended Release
Product Images NDC 68462-319

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 68462-319). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

500mg 60 Tablets

500mg 60 Tablets
This is a medication label for Ranolazine extended-release tablets by Glenmark. It contains instructions on how to consume the tablets and the details of the medicine, including its name, strength (60 tablets), and NDC (68462-319-60).*
FDA Label Image

Bottle 1000mg 60 Tablets

FDA Label Image
FDA Label Image
FDA Label Image

Structure (Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.